View Older Stories View More Recent Stories
-
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
-
Csquare prices IPO at $21 per share on NYSE
-
Csquare, Inc. Announces Pricing of Initial Public Offering
-
Obsidian Energy Announces $75 million Add-On to our Existing Senior Unsecured Notes
-
Platinum Group Metals Ltd. Reports Third Quarter 2026 Results
-
Brompton Split Banc Corp. Announces Successful Preferred Share Offering
-
Alliant Energy (LNT) PT Raised to $83 at BMO Capital
-
Goldman Sachs (GS) PT Raised to $1,190 at BMO Capital
-
Visa (V) PT Raised to $387 at BMO Capital
-
Phoenix Education Partners (PXED) PT Lowered to $36 at BMO Capital
-
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
-
Railmark Acquires Katahdin Railcar Services LLC
-
US consumer inflation moderates; upside risks remain amid renewed Middle East conflict
-
Life & Banc Split Corp. Completes Preferred Share Offering
-
MDA Space raises $819M in share offering to fund CLS acquisition
-
MDA SPACE ANNOUNCES CLOSING OF ITS UPSIZED BOUGHT DEAL OFFERING OF COMMON SHARES
-
BMO Capital 'Expecting In-Line Quarter' for Murphy Oil Corp. (MUR)
-
Sibyane Stillwater (SBSW) PT Lowered to $12 at BMO Capital
-
Cadillac Mines Corporation Files Preliminary Prospectus For Initial Public Offering
-
C.H. Robinson Worldwide (CHRW) PT Raised to $190 at BMO Capital
-
BMO Capital Starts RXO, Inc. (RXO) at Outperform, 'Well Positioned To Leverage TL Market Tightening'
-
Bank of America hires nine senior investment bankers to target US middle market
-
Bank of America adds nine senior bankers to regional investment banking unit
-
Bank of America Expands Regional Investment Banking Coverage, Adds Nine Key Senior Hires Across the U.S.
-
DTE Energy (DTE) PT Lowered to $152 at BMO Capital
-
BMO Capital on Chevron (CVX): 'Fully Ramped at the Ideal Time'
-
Chiron Real Estate Inc (XRN) PT Raised to $40 at BMO Capital
-
Merck (MRK) PT Raised to $142 at BMO Capital
-
Incyte (INCY) PT Raised to $112 at BMO Capital
-
Abbvie (ABBV) PT Raised to $300 at BMO Capital
-
Pfizer (PFE) PT Lowered to $30 at BMO Capital
-
Neurocrine Bio. (NBIX) PT Raised to $170 at BMO Capital
-
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
-
Holtec Nuclear Corporation Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Holtec Nuclear Corporation files for initial public offering
-
BMO Capital on Permian Resources Corp (PR): 'Expecting Strong Execution to Continue'
-
Rubrik Inc (RBRK) PT Raised to $98 at BMO Capital on 'Durable Growth Potential'
-
BMO Capital: 'Allstate (ALL) Biggest Beneficiary of Insurance Reforms'
-
BMO Capital Starts Roper Industries (ROP) at Market Perform
-
BMO Capital Starts Roper Industries (ROP) at Market Perform
-
MDA Space raises share offering to $819M to fund CLS acquisition
-
MDA Space Increases Previously Announced Bought Deal Offering of Common Shares
-
BMO Capital Starts Lexington Realty Trust (LXP) at Outperform
-
BMO Capital Starts Integra LifeSciences (IART) at Market Perform
-
BMO Capital Starts Straumann Holding AG (STMN:SW) (SAUHF) at Outperform
-
BMO Capital Starts Stryker (SYK) at Outperform
-
BMO Capital Starts Align Technology (ALGN) at Outperform
-
BMO Capital Starts Envista Holdings Corp. (NVST) at Market Perform
-
BMO Capital Starts Alphatec Holdings (ATEC) at Outperform
-
BMO Capital Starts Solventum (SOLV) at Market Perform
